
Home > Science > Research & Development > R&D Pipeline
R&D Pipeline
Our robust R&D pipeline is the cornerstone of our growth strategy. A firm belief in ‘our pipeline is our lifeline’ drives our substantial investments in research and development. A cutting-edge R&D platform has enabled us to build a strategic pipeline of biosimilar molecules for the benefit of patients, globally.
We currently have several assets spanning multiple therapeutic areas in various stages of development, encompassing mAbs, insulin analogs, and conjugated recombinant proteins.

Related Links

Unlike small molecules that are chemically synthesized, protein therapeutics are produced from living organisms, including microbes or cells, making them...

Biocon Biologics’ world-class Research & Development (R&D) centers in Bengaluru and Chennai are integral to our mission of developing high-quality,...